宇學峯

宇學峯在生物醫藥領域深耕30多年。在加入康希諾生物之前，宇學峯曾就職於加拿大IBEX Biotechnologies Inc.，任產品研發科學家，從事藥用酶製劑的研發；1998年加入全球五大疫苗企業之一賽諾菲巴斯德（Sanofi Pasteur Limited.），先後擔任產品開發部科學家、細菌疫苗開發部加拿大分部總監及細菌疫苗開發全球總監。 ^{[5-6]  [9]} 

創辦康希諾生物十多年來，宇學峯不斷吸引國內外疫苗行業的頂尖人士加入，為康希諾生物組建了一支頂尖人才隊伍，帶領團隊建立了針對12種疾病的17款疫苗產品的研發管線，其中重組埃博拉病毒病疫苗(Ad5-EBOV)於2017年獲批上市，成為亞洲首個獲批的重組埃博拉病毒病疫苗。2021年2月25日，康希諾生物研發的重組新型冠狀病毒疫苗（5型腺病毒載體）克威莎® 獲得國家藥品監督管理局批准附條件上市，成為中國首個獲批的腺病毒載體新冠疫苗。 ^[9] 

同時，宇學峯還主導建設了康希諾生物疫苗產業化生產基地，其設計、建設和運營均符合國際GMP標準。 ^[8-9] 

成功的完成了三個新疫苗（人乳頭瘤病毒疫苗，炭疽重組蛋白疫苗，衣原體重組蛋白疫苗）的臨牀前研發，四個新疫苗（中耳炎疫苗，肺炎重組蛋白疫苗，7和13價肺炎結合疫苗，的臨牀1期研發，兩個新疫苗（肺結核重組蛋白疫苗，老年肺炎重組蛋白疫苗）的臨牀2期研發。

1. Yu, X. Application of Innovative Technologies to Vaccine Process Development. Invited panel presentation, IBC 2nd Annual Vaccine Asia conference. Nov 10-13, 2008. Beijing, China。

2. Yu, X. Leverage key Success Factors to Strategically Develop an Effective Technology Transfer Process. Invited speaker, CMO Partnerships for Successful Technology Transfer. July 30- August 1, 2007, Institute of International Research, Boston, MA.

3. Yu, X. Application of PAT principals in Process Development in Sanofi Pasteur, Invited speaker. IBC’s 3rd International Implementing Process Analytical Technologies (PAT) for Bioprocessing July 17-19, 2006, Reston, Virginia。

4. Matheson, K.; Yu, X. Evaluation of microarray technology as a tool for host strain assessment and process optimization. Invited speaker and session Chairman, Recent Advances in Fermentation Technology (RAFT IV) Nov 6-9 2005, Long Beach, CA.

5. Yu, X.; D’Amore, T. Fermentation Process Development to Optimize Recombinant Proteins Expression in Escherichia coli, Recent Advances in Fermentation Technology (RAFT III), Nov. 2001, Sarasota, FL.

6. Yu, X.; D’Amore, T. Fermentation Process Development to Optimize Recombinant Protein Expression in E. coli for Otitis Media Vaccine Production, SIM Annual meeting, July 200。

7. Yu, X.; Hallett, S. G.; Sheppard, J.; Watson, A. K. Effects of carbon concentration and carbon-to-nitrogen ratio on growth, conidiation, spore germination and efficacy of the potential bioherbicide Colletotrichum coccodes. Journal of Industrial Microbiology & Biotechnology (1998), 20(6), 333-338.

8. Yu, X.; Hallet, S. G.; Sheppard, J.; Watson, A. K. Application of the Plackett-Burman experimental design to evaluate nutritional requirements for the production of Colletotrichum coccodes spores. Applied Microbiology and Biotechnology (1997), 47(3), 301-305.

9. Yu, X.; Gu, K. High Cell Density Fermentation of Recombinant E. coli Expressing Phenylalanine Ammonia Lyase, IBEX Technologies Inc., Montreal, QC, Canada, Recent Advances in Fermentation Technology (RAFT II), Nov 1997, San Diego, CA。

10. Yu, X., Hallett, S., Sheppard, J. and Watson A.K. Production of Spores of Colletotrichum coccodes in a Cyclone Column Bioreactor, Canadian Society for Microbiology Annual Meeting, July 1995, Kingstown, Canada。

11. Yu, X, Hallett, S. and Watson, A.K. Development of an efficient and cost effective growth medium for Colletotrichum coccodes. II International Bioherbicides Workshop, 1992, Montreal, Canad。

12. Zhou, Y.L., Shi, G.L., Zhou, J.Y., Long, T.J., Li, M.L., Yu, X. and Zhang, J., 1991, Yeasts of Bohai Seawater. Acta Mycologica Sinica, Vol.10(1), 36-42。

13. Zhou, Y.L., Xing, L.J., Wang, Y.X., Liu, R.L., Wang, H.M., Yu, X. and Liu, F. 1990, High-protein Content of Strains of Fusarium for Food Potentials. The Fourth International Mycological Congress, FRG。

14. Zhou, Y.L., Xing, L.J., Wang, H.M., Yu, X. and Liu, F. 1990, Studies on Nutrient Condition for Protein-producing Fusarium. The Third National Symposium on Fungi and Lichens, Mycological Society of China Beijing。

15. Yu, X., Song, L.S. and Wang, Y.W., 1990, Auxotroph Selection of Aureobasidium pullulans and the Formation and Regeneration of its Protoplast. Acta Scientiarum Naturalium Universitatis Nankaiensis No.1, 101-103。

16. Wang, Y.W., Yu, X., Wang, H.M., Song, L.S. and Zhou, Y.L., 1990, Electric Field-induced Intergeneric Protoplast Fusion Between Saccharomyces cerevisiae and Aureobasidium pullulans. Acta Mycologica Sinica, Vol.9(1), 56-63.

17. Zhou, Y.L., Li, M.L., Wang, H.M., Yu, X., Liu, F., Zhang J. and Hu G., 1990, Yeasts From Different Substrata Along Bohai Seacoast. Acta Scientiarum Naturalium Universitatis Nankaiensis, No.4, 57-61.

2022年8月2日，津商聯合會正式宣佈成立，出任津商聯合會共同主席。 ^[10] 

2019年，擔任天津市生物醫藥產業專家 諮詢委員會委員

2019年3月，擔任南開大學特聘教授

2020年12月，被評選為“天津市發改委決策諮詢專家” ^[3] 

2020年12月，被評選為 創業邦2020年度創業人物 ^[4] 

2021年10月，入選天津市企業家隊伍建設“111”工程“傑出企業家”培養對象

2021年11月，擔任第一屆全國博士後創新創業大賽導師 ^[3] 

^[1] 

學科方向：藥理學。

招生方向：藥理學。

2021年4月，宇學峯以12億美元財富位列《2021福布斯全球富豪榜》第2378位。 ^[2] 

南開校友企業家聯誼會共同主席 ^[11] 

南開大學天津校友會聯席會長 ^[12]